Aimo et al.1 presented an elegant review of the antiviral mechanism of amiodarone, which is a commonly used antiarrhythmic drug. Although in vitro experiments demonstrated the ability of amiodarone to inhibit coronavirus, we are still wary of the authors’ recommendation to evaluate amiodarone for the treatment of coronavirus disease 2019 (COVID-19) in clinical trials.
|Number of pages||1|
|Journal||European Journal of Preventive Cardiology|
|Early online date||12 Nov 2020|
|Publication status||Published - 9 Feb 2022|